0000000001291518

AUTHOR

Hong Liu

showing 5 related works from this author

Study of the exclusive initial-state-radiation production of the D¯¯¯D system

2006

A study of exclusive production of the $D \bar D$ system through initial-state r adiation is performed in a search for charmonium states, where $D=D^0$ or $D^+$. The $D^0$ mesons are reconstructed in the $D^0 \to K^- \pi^+$, $D^0 \to K^- \pi^+ \pi^0$, and $D^0 \to K^- \pi^+ \pi^+ \pi^-$ decay modes. The $D^+$ is reconstructed through the $D^+ \to K^- \pi^+ \pi^+$ decay mode. The analysis makes use of an integrated luminosity of 288.5 fb$^{-1}$ collected by the BaBar experiment. The $D \bar D$ mass spectrum shows a clear $\psi(3770)$ signal. Further structures appear in the 3.9 and 4.1 GeV/$c^2$ regions. No evidence is found for Y(4260) decays to $D \bar D$, implying an up per limit $\frac{\…

Nuclear and High Energy PhysicsParticle physicsMesonBABARElectron–positron annihilationFOS: Physical sciencesRadiationPARTICLE PHYSICS; PEP2; BABAR01 natural sciencesParticle identificationHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)BABAR experimentTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical sciencesPEP2[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010306 general physicsPhysics010308 nuclear & particles physicsParticle physicsState (functional analysis)HEPCrystallographyBaBarMass spectrumPARTICLE PHYSICSProduction (computer science)14.40.Lb 13.25.Ft 12.40.YxFísica de partículesExperimentsBar (unit)
researchProduct

Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).

2013

Antitumor activityNeurotransmitter AgentsDrug Industrybusiness.industryChemistrychemistry.chemical_elementNanotechnologyFluorine containingAntineoplastic AgentsGeneral ChemistryFluorineLegislation DrugAntiviral AgentsCommerceAnti-Infective AgentsPharmaceutical PreparationsFluorineHypoglycemic AgentsbusinessGlucocorticoidsPharmaceutical industryHypolipidemic AgentsChemical reviews
researchProduct

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and…

2017

Background There is a need for hepatitis C virus (HCV) therapies with excellent efficacy across genotypes and in diverse populations. Part A of the C-CREST-1 and C-CREST-2 trials led to the selection of a three-drug regimen of grazoprevir (MK-5172; an HCV NS3/4A protease inhibitor; 100 mg/day) plus ruzasvir (MK-8408; an NS5A inhibitor; 60 mg/day) plus uprifosbuvir (MK-3682; an HCV NS5B polymerase inhibitor; 450 mg/day). Part B of the studies tested this combination as a single formulation in different treatment durations in a broader population. Methods Part B of these randomised, phase 2, open-label clinical trials enrolled individuals from 15 countries who were chronically infected with H…

CyclopropanesLiver CirrhosisMalePyrrolidinesSustained Virologic ResponseGastroenterologychemistry.chemical_compound0302 clinical medicinePegylated interferonGenotype030212 general & internal medicineSulfonamideseducation.field_of_studyGastroenterologyHepatitis CMiddle Aged10219 Clinic for Gastroenterology and HepatologyGrazoprevirHCVFemale030211 gastroenterology & hepatologymedicine.drugAdultmedicine.medical_specialtyGenotypePopulationFixed-dose combination610 Medicine & healthAntiviral AgentsHeterocyclic Compounds 4 or More RingsDrug Administration Schedule03 medical and health sciencesQuinoxalinesInternal medicineRibavirinmedicineHumans2715 GastroenterologyeducationUridinetherapyHepatologybusiness.industryRibavirinHepatitis C Chronicmedicine.diseaseAmidesThiazolesRegimenchemistryImmunology2721 HepatologyCarbamatesbusiness
researchProduct

Search for Diphoton Events with Large Missing Transverse Energy with 36 pb^-1 of 7 TeV Proton-Proton Collision Data with the ATLAS Detector

2011

Making use of 36 pb^-1 of proton-proton collision data at sqrt{s} = 7 TeV, the ATLAS Collaboration has performed a search for diphoton events with large missing transverse energy. Observing no excess of events above the Standard Model prediction, a 95% Confidence Level (CL) upper limit is set on the cross section for new physics of sigma < 0.38 - 0.65 pb in the context of a generalised model of gauge mediated supersymmetry breaking (GGM) with a bino-like lightest neutralino, and of sigma < 0.18 - 0.23 pb in the context of a specific model with one universal extra dimension (UED). A 95 % CL lower limit of 560 GeV, for bino masses above 50 GeV, is set on the GGM gluino mass, while a low…

Physics and Astronomy (miscellaneous)Physics beyond the Standard ModelParticleProton–proton collision01 natural sciencesHigh Energy Physics - ExperimentUniversal extra dimensionHigh Energy Physics - Experiment (hep-ex)Diphoton eventsExtension[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear ExperimentPhysicsCompactification (physics)Settore FIS/01 - Fisica SperimentaleSigmaSupersymmetryATLASTransverse planePhysical SciencesDynamical Supersymmetry BreakingUniversal Extra DimensionsFísica nuclearPhenomenologyLHCPhenomenology (particle physics)Particle Physics - ExperimentParticle physicsFortran CodeSupergauge TransformationsFOS: Physical sciencesproton–proton collision; ATLAS detectorddc:500.25300103 physical sciencesFysikddc:530High Energy Physics010306 general physicsEngineering (miscellaneous)Ciencias Exactas010308 nuclear & particles physicsFísicaCollisionHadron CollidersGeneratorsCol·lisions (Física nuclear)High Energy Physics::ExperimentSupersymmetryModel
researchProduct

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

2020

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347

MaleOriginalmedicine.medical_treatmentartificialCritical Care and Intensive Care MedicineMedical and Health SciencesPressure ulcerlaw.inventionDecubitus epidemiology; ICU; Morbidity; Mortality; Outcome; Pressure injury; Pressure ulcer; Risk factors; Adult; Aged; Hospital Mortality; Humans; Male; Patient Discharge; Prevalence; Risk Factors; Intensive Care Units; Respiration Artificial0302 clinical medicineDecubitus epidemiologydecubitus epidemiology ; ICU ; pressure injury ; pressure ulcer ; outcome ; risk factors ; morbidity ; mortalitylawMedicine and Health SciencesadultsPrevalenceMedicineHospital MortalitySimplified Acute Physiology Scoredecubitus epidemiology; icu; pressure injury; pressure ulcer; outcome; risk factors; morbidityziekenhuissterfteImmunodeficiencyintensive careOutcomeEuropean Society of Intensive Care Medicine (ESICM) Trials Group CollaboratorsmannenvolwassenenCOSTIntensive care unitSTATEPatient DischargeIntensive Care UnitsULCERSUnderweightmedicine.symptomLife Sciences & BiomedicineDecubitus epidemiology; ICU; Morbidity; Mortality; Outcome; Pressure injury; Pressure ulcer; Risk factorsHumanAdultmedicine.medical_specialtyrisicofactorenDecubitus epidemiology ICU Pressure injury Pressure ulcer Outcome Risk factors Morbidity Mortalitypressure injuriesIntensive Care UnitprevalentieNO1117 Public Health and Health ServicesDecubICUs Study Team03 medical and health sciencesCritical Care MedicineAnesthesiologyGeneral & Internal MedicineHealth SciencesouderenHumansMortalityAgedMechanical ventilationScience & Technologybusiness.industrydecubitusRisk Factor030208 emergency & critical care medicine1103 Clinical SciencesOdds ratiomedicine.diseaseRespiration ArtificialEmergency & Critical Care MedicineConfidence interval030228 respiratory systemRisk factorsEmergency medicineICUkunstmatige ademhalingRISK-FACTORSMorbiditybusinessPressure injuryrespiration
researchProduct